![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SM Toggas, JK Krady and ML Billingsley
Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey 17033.
The molecular basis of selective vulnerability of specific neuronal populations to neurotoxicants remains a key focus in neurotoxicology. Trimethyltin (TMT) selectively damages neurons in rodent and human central nervous system after a single exposure. By coupling subtractive hybridization with molecular cloning techniques, we isolated a cDNA specifically localized in TMT-sensitive cells. This 2.9-kilobase cDNA encodes a putative 10-kDa peptide of 88 amino acids, termed "stannin." In immunocytochemical experiments, antisera raised against the amino terminus of stannin exhibited strong immunoreactivity in TMT-sensitive neurons in the hippocampus and entorhinal cortex, areas previously identified by in situ hybridization. Northern blot and in situ hybridization experiments detected a 3.0-kilobase stannin mRNA in brain, spleen, and kidney; expression occurred as early as embryonic day 15 in rat brain and thymus. In situ hybridization in human hippocampus demonstrated a stannin mRNA in pyramidal and dentate gyrus neurons. High stringency Southern blot analysis of genomic DNA identified stannin homologs in rabbit, Drosophila, and human. These findings indicate that stannin is present in TMT-sensitive cells and may play a role in the selective toxicity of organotin compounds.
This article has been cited by other articles:
|
|
 |
|
  B. E. Reese, C. Davidson, M. L. Billingsley, and J. Yun Protein Kinase C{epsilon} Regulates Tumor Necrosis Factor-{alpha}-Induced Stannin Gene Expression J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 61 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Davidson, B. E. Reese, M. L. Billingsley, and J. K. Yun Stannin, A Protein That Localizes to the Mitochondria and Sensitizes NIH-3T3 Cells to Trimethyltin and Dimethyltin Toxicity Mol. Pharmacol., October 1, 2004; 66(4): 855 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rezvani, J.D. Barrans, K.-S. Dai, and C.-C. Liew Apoptosis-related genes expressed in cardiovascular development and disease: an EST approach Cardiovasc Res, February 1, 2000; 45(3): 621 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Philbert, M. L. Billingsley, and K. R. Reuhl Mechanisms of Injury in the Central Nervous System Toxicol Pathol, January 1, 2000; 28(1): 43 - 53. [Abstract] [PDF]
|
|
|
|
 |
|
 A De Santiago and M Aguilar-Santelises Organotin compounds decrease in vitro survival, proliferation and differentiation of normal human B lymphocytes Human and Experimental Toxicology, October 1, 1999; 18(10): 619 - 624. [Abstract] [PDF]
|
|
|
|
 |
|
 A. J.G. Horrevoets, R. D. Fontijn, A. J. van Zonneveld, C. J.M. de Vries, J. W. ten Cate, and H. Pannekoek Vascular Endothelial Genes That Are Responsive to Tumor Necrosis Factor-{alpha} In Vitro Are Expressed in Atherosclerotic Lesions, Including Inhibitor of Apoptosis Protein-1, Stannin, and Two Novel Genes Blood, May 15, 1999; 93(10): 3418 - 3431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. B. NGIMBOUS, F. BOURGEOIS, C. MAS, M. SIMONNEAU, and J.-M. MOALIC Heart transplantation changes the expression of distinct gene families Physiol Genomics, December 21, 2001; 7(2): 115 - 126. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
